Dehaier Medical Systems Ltd  

(Public, NASDAQ:DHRM)   Watch this stock  
Find more results for DHRM
1.74
0.00 (0.00%)
Real-time:   11:14AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.26 - 3.95
Open     -
Vol / Avg. 0.00/4,065.00
Mkt cap 7.95M
P/E 2.61
Div/yield     -
EPS 0.67
Shares 4.57M
Beta     -
Inst. own     -
May 10, 2012
Q1 2012 Dehaier Medical Systems Ltd Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 3.94% 14.44%
Operating margin 13.72% 16.69%
EBITD margin - 18.77%
Return on average assets 1.52% 8.70%
Return on average equity 1.75% 11.65%
Carbon Disclosure Rating - -

Address

Room 501 4th Ring North Road,Haidian District
BEIJING, BEJ 100856
China
+86-10-51660080 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Dehaier Medical Systems Limited (Dehaier) designs, develops and markets its branded products in China. The Company imports the majority of the products and medical components it sells to its customers. The Company designs and develops some of the medical components that are part of the branded products to be distributed. Some of these medical components are manufactured by contractors in China because it does not have a manufacturing facility. Most of its branded products require light assembly. The Company focuses on the development and distribution of medical devices. In addition to Dehaier�s branded products, it also serves as a distributor of products designed and manufactured by other companies. The Company broadens product portfolio through distribution agreements with international manufacturers. In May 2012, the Company announced that it established a wholly owned United States subsidiary, BreathCare, LLC.

Officers and directors

Ping Chen Chairman of the Board, Chief Executive Officer
Age: 48
Bio & Compensation - Reuters
Yanying Qi Chief Financial Officer
Age: 32
Bio & Compensation - Reuters
Weibing Yang Vice President - Sales and Marketing, Director
Age: 45
Bio & Compensation - Reuters
Genhui Chen Ph.D. Independent Director
Age: 48
Bio & Compensation - Reuters
Yunxiang Fan Independent Director
Age: 45
Bio & Compensation - Reuters
Mingwei Zhang Independent Director
Age: 58
Bio & Compensation - Reuters